<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03148548</url>
  </required_header>
  <id_info>
    <org_study_id>ILIACA-PTS</org_study_id>
    <nct_id>NCT03148548</nct_id>
  </id_info>
  <brief_title>Substudy - Evaluation of Patients With Iliac Vein Thrombosis</brief_title>
  <official_title>Iliofemoral Thrombosis and Postthrombotic Syndrome: Registration and Analysis Within the Frankfurt Thrombophilia Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardioangiologisches Centrum Bethanien</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardioangiologisches Centrum Bethanien</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with previous diagnosis of iliac vein thrombosis are enrolled in this registry.
      Using standardized questionnaire, clinical data detailing venous thromboembolism and
      contributing VTE risk factors are recorded. Results of technical and laboratory
      investigations including screening of thrombophilic disorders were additionally entered into
      the database.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>3 Days</target_duration>
  <primary_outcome>
    <measure>Incidence and severity of postthrombotic Syndrome after iliofemoral thrombosis</measure>
    <time_frame>up to 20 years after occurrence of iliofemoral thrombosis</time_frame>
    <description>The incidence and severity of postthrombotic Syndrome will be measured by te VILALLTA-Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Distribution of gender in Iliofemoral thrombosis</measure>
    <time_frame>since 1996</time_frame>
    <description>Distribution of gender (man or woman)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of affected side in Iliofemoral thrombosis</measure>
    <time_frame>since 1996</time_frame>
    <description>distribution of affected side (left or right side)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>Quality of life questionaire VEINES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of venous claudication</measure>
    <time_frame>1 year</time_frame>
    <description>Walking distance on treadmill</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">85</enrollment>
  <condition>Iliac Vein Thrombosis</condition>
  <arm_group>
    <arm_group_label>Patients with iliofermoral thrombosis without rekanalisation</arm_group_label>
    <description>subjects with proven iliofemoral thrombosis (V. cava-aplasia, pelvic vein thrombosis, VTE) which was proven by objective methods such as Duplex sonography, CT/MRT, phlebography and who did not undergo recanalisation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with ilifermoral thrombosis with rekanalisation</arm_group_label>
    <description>subjects with proven iliofemoral thrombosis (V. cava-aplasia, pelvic vein thrombosis, VTE) which was proven by objective methods such as Duplex sonography, CT/MRT, phlebography and who did undergo recanalisation</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>thrombophilia screening</intervention_name>
    <description>genetic Evaluation of Factor-V-Leiden, Factor-II_G20210A Mutation;</description>
    <arm_group_label>Patients with iliofermoral thrombosis without rekanalisation</arm_group_label>
    <arm_group_label>Patients with ilifermoral thrombosis with rekanalisation</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blodd, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with previous iliofermoral thrombosis, which has been proven by objective
        measurements (Duplex sonography, phlebography, CT/MRT)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years

          -  subjects with iliofermoral thrombosis, which has been proven by objective measurements
             (Duplex sonography, phlebography, CT/MRT) later than 1996

        Exclusion Criteria:

          -  &lt;18 years

          -  &gt; 80 years

          -  surface or deep vein thrombosis without affection of pelvis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edelgard Lindhoff-Last, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardioangiologisches Zentrum Bethanien</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardioangiologisches Centrum Bethanien</name>
      <address>
        <city>Frankfurt/Main</city>
        <state>Hessen</state>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2017</study_first_submitted>
  <study_first_submitted_qc>May 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VTE</keyword>
  <keyword>thrombophilia screening</keyword>
  <keyword>patients</keyword>
  <keyword>risk factors</keyword>
  <keyword>post-thrombotic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Thrombophilia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

